FDA Approves Amgen's Denosumab For First Oncology Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
Known as Prolia for osteoporosis, the drug will be called Xgeva for skeletal-related events related to metastasized solid-tumor cancers.